ZYBT Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: August 26, 2025

Report Source: 2024 Annual Report

Zhengye Biotechnology Holding Ltd

Zhengye Biotechnology Holding Ltd. Stock Analysis ZYBT

United States Health Care Small Cap Report:
Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. The company is headquartered in Jilin, Jilin and currently employs 275 full-time employees. The company went IPO on 2025-01-07. The firm markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The firm owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The firm also engages in vaccines for treating livestock. The firm mainly conducts its business in the domestic market. The firm mainly conducts its business in the domestic and overseas market.
Read More

Zhengye Biotechnology Holding Ltd (ZYBT) Chart

Key Statistics of Zhengye Biotechnology Holding Ltd (ZYBT)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$4.84$7.03

Today's Open

$6.91

Volume

1.33M

P/E Ratio (TTM)

318.18

52 Week Range

$3.50$14.30

Market Cap

355.91M

Avg. Volume

285.49K

Dividend Yield

0.45%

Financial Metrics & Statements of Zhengye Biotechnology Holding Ltd (ZYBT)

FAQ's for Zhengye Biotechnology Holding Ltd (ZYBT)

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.